The First FDA-Approved Digital Pill — What It Means For Pharma Harsha Madannavar Justin Wang Helen Chen Read more
Related Practice Life Sciences & Pharma In mid-November 2017, the U.S. FDA approved Japan-based Otsuka Pharmaceutical’s Abilify MyCite— a first for digital medicine. 07312019140709
Special Report Business Services Look Forward 2026: Strategic Priorities for Creating Value February 11, 2026
Published Articles Life Sciences & Pharma Investing in Psychedelic Therapies: Market Challenges and Opportunities December 23, 2025
Special Report Contract/Pharma Services Advancing Innovation and Global Reach: The Next Chapter in China’s Clinical Trial… November 12, 2025
Video / Webinar Life Sciences & Pharma Navigating China's Volume-Based Procurement in the Pharma Industry August 27, 2025
Executive Insights Life Sciences & Pharma From Bench to Bedside: Academic-to-Industry Translation in European Biopharma June 25, 2025